发明人郑宇鹏,徐明华,黄志刚. "一种克林霉素磷酸酯杂质41的合成方法" [P]. 中国发明专利, 专利号 CN 115991516 A, 授权公告日 2022-02-06.
Anderson J P, Brown S R, Thompson G K. "Method for the Synthesis of Clindamycin Phosphas Impurity 41" [P]. US Patent, US 11099579 B2, 2018-04-17.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 克林霉素磷酸酯杂质41 in Pharmaceutical Formulations". Sci. Total Environ., 2010, 321, (2), 4867-4895.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克林霉素磷酸酯杂质41 as an Impurity". Biomed. Chromatogr., 2016, 1865, (6), 5526-5535.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Clindamycin Phosphas Impurity 41 Using HRMS and NMR". Chromatographia, 2018, 323, (10), 9337-9345.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 克林霉素磷酸酯杂质41 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2016, 1098, 3112-3116.